Sevion Therapeutics Inc (SVON) - Financial and Strategic SWOT Analysis Review

  • ID: 4281541
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary:

Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic acids and other payloads to target cells. Its product pipeline includes SVN-00, SVN-002, SVN-003, multiple GPCR targets and ion channel. The company’s SVN-002 is an antibody against an oncology target that has the potential to impact metastatic tumors, which include resistant to anti-VEGF treatments. Sevion is headquartered in San Diego, California, the US.

Sevion Therapeutics Inc Key Recent Developments

Sep 26, 2017: Eloxx Pharmaceuticals Appoints Gregory Weaver as Chief Financial Officer
Mar 10, 2016: Harlan Waksal, M.D. resigns as Chairman of the Board of Sevion Therapeutics

This comprehensive SWOT profile of Sevion Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Sevion Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Sevion Therapeutics Inc - Key Information
  • Sevion Therapeutics Inc - Overview
  • Sevion Therapeutics Inc - Key Employees
  • Sevion Therapeutics Inc - Key Employee Biographies
  • Sevion Therapeutics Inc - Key Operational Heads
  • Sevion Therapeutics Inc - Major Products and Services
  • Sevion Therapeutics Inc - History
  • Sevion Therapeutics Inc - Company Statement
  • Sevion Therapeutics Inc - Locations And Subsidiaries
  • Sevion Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Sevion Therapeutics Inc - Business Description
  • Sevion Therapeutics Inc - Corporate Strategy
  • Sevion Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Sevion Therapeutics Inc - Strengths
  • Sevion Therapeutics Inc - Weaknesses
  • Sevion Therapeutics Inc - Opportunities
  • Sevion Therapeutics Inc - Threats
  • Sevion Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Sevion Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Sevion Therapeutics Inc, Key Information
  • Sevion Therapeutics Inc, Key Ratios
  • Sevion Therapeutics Inc, Share Data
  • Sevion Therapeutics Inc, Major Products and Services
  • Sevion Therapeutics Inc, History
  • Sevion Therapeutics Inc, Key Employees
  • Sevion Therapeutics Inc, Key Employee Biographies
  • Sevion Therapeutics Inc, Key Operational Heads
  • Sevion Therapeutics Inc, Other Locations
  • Sevion Therapeutics Inc, Subsidiaries
  • Sevion Therapeutics Inc, Key Manufacturing facilities
  • Sevion Therapeutics Inc, Key Competitors
  • Sevion Therapeutics Inc, SWOT Analysis
  • Sevion Therapeutics Inc, Ratios based on current share price
  • Sevion Therapeutics Inc, Annual Ratios
  • Sevion Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sevion Therapeutics Inc, Performance Chart
  • Sevion Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll